Under a memorandum of understanding, Agilent will provide DGIST with early access to novel technology and software development. The center will also be a reference site for Agilent customers in Asia who are interested in metabolomics and brain science.

"Metabolomics is a powerful, emerging discipline with a broad range of applications, and for many years Agilent has been collaborating with leading universities on clinical research, drug development, environmental toxicology, crop optimization and food science," said Rod Minett, general manager of Agilent's life sciences business in South Korea and the South Asia Pacific region.

"Today, we have the chance to be involved in metabolomics research for neuroscience as our instruments can help scientists obtain and analyze data quickly and reliably. Importantly, we work with them to investigate questions they couldn't answer before."

Agilent is a leading provider of measurement solutions for metabolomics with the comprehensive product portfolio that spans the metabolomics workflow. Metabolomics is one of the fastest growing areas of life sciences research. Other areas of Agilent's life sciences business include genomics, proteomics, bioinformatics and pharmaceutical analysis.